The Interaction Between FAK, MYCN, p53 and Mdm2 in Neuroblastoma

E-ISSN： 1875-5992|14|1|46-51

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.14, Iss.1, 2014-01, pp. : 46-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma

By Megison Michael

Clinical and Experimental Metastasis, Vol. 30, Iss. 5, 2013-06 ,pp. : 555-568

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic Value of Mdm2, p53 and p16 in Patients with Astrocytomas

By Ranuncolo Stella Varela Mirta Morandi Ana Lastiri José Christiansen Silvia Bal de Kier Joffé Elisa Pallotta María Puricelli Lydia

Journal of Neuro-Oncology, Vol. 68, Iss. 2, 2004-06 ,pp. : 113-121

Springer Publishing Company

Access to resources Recommend Favorite

A Small-molecule Inhibitor, 5'-O-Tritylthymidine, Targets FAK and Mdm-2 Interaction, and Blocks Breast and Colon Tumorigenesis in vivo

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 4, 2013-05 ,pp. : 532-545

Bentham Science Publishers

Access to resources Recommend Favorite

Potential genotype-specific single nucleotide polymorphism interaction of common variation in p53 and its negative regulator mdm2 in cholangiocarcinoma susceptibility

Oncology Letters, Vol. 4, Iss. 1, 2012-01 ,pp. : 101-106

Spandidos Publications

Access to resources Recommend Favorite

The interaction between p53 and papillomaviruses

By Mantovani F. Banks L.

Seminars in Cancer Biology, Vol. 9, Iss. 6, 1999-12 ,pp. : 387-395

Academic Press

Access to resources Recommend Favorite